Literature DB >> 11738859

Bone histomorphometry in three females with Rett syndrome.

S S Budden1, M E Gunness.   

Abstract

The frequent occurrence of osteoporosis in Rett syndrome raises questions about the etiology of this finding. It is unknown whether there is any relationship between low bone mass and the underlying genetic disorder. We recently had an opportunity to study the status of bone remodeling by quantitative bone histomorphometry in three girls ages 9.75, 13.5, and 14 years, with typical Rett syndrome who required scoliosis surgery.Anterior iliac crest bone biopsies were performed 1-2 days after double labeling of the bone surfaces with tetracycline. Samples were processed for plastic embedding, sectioned, stained, and histomorphometry performed in the cancellous bone. The same observer performed all measurements. Bone volume was reduced, surface parameters of formation (osteoid surface) were normal while parameters of resorption (osteoclast surface and number) were decreased. The rate of bone formation was reduced in the first two girls but could not be measured in the third girl due to lack of double labeling. It may be that the slow rate of bone formation seen in each age group impedes the development and accumulation of peak bone mass and contributes to the decreased bone volume associated with Rett syndrome, although the data is limited. This is the first report to document decreased bone volume determined by quantitative bone histomorphometry in patients with Rett syndrome. With the recent identification of MECP2 mutations in Rett syndrome it is quite likely that genetic factors not only play a major role in brain development but may also influence other organ growth including bone formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738859     DOI: 10.1016/s0387-7604(01)00338-2

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  6 in total

1.  Low bone mineral mass is associated with decreased bone formation and diet in girls with Rett syndrome.

Authors:  Kathleen J Motil; Judy O Barrish; Jeffrey L Neul; Daniel G Glaze
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-09       Impact factor: 2.839

Review 2.  Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.

Authors:  Christopher A Chapleau; Jane Lane; Lucas Pozzo-Miller; Alan K Percy
Journal:  Curr Clin Pharmacol       Date:  2013-11

3.  Osteoporosis in Rett syndrome: a case study presenting a novel management intervention for severe osteoporosis.

Authors:  M Lotan; R Reves-Siesel; R S Eliav-Shalev; J Merrick
Journal:  Osteoporos Int       Date:  2013-07-05       Impact factor: 4.507

Review 4.  Osteoporosis in children and adolescents: etiology and management.

Authors:  Giampiero Igli Baroncelli; Silvano Bertelloni; Federica Sodini; Giuseppe Saggese
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

5.  Bone microarchitecture in Rett syndrome and treatment with teriparatide: a case report.

Authors:  M B Zanchetta; M F Scioscia; J R Zanchetta
Journal:  Osteoporos Int       Date:  2016-04-11       Impact factor: 4.507

6.  Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome.

Authors:  R D O'Connor; M Zayzafoon; M C Farach-Carson; N C Schanen
Journal:  Bone       Date:  2009-05-03       Impact factor: 4.398

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.